BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murrough JW, Yaqubi S, Sayed S, Charney DS. Emerging drugs for the treatment of anxiety. Expert Opin Emerg Drugs 2015;20:393-406. [PMID: 26012843 DOI: 10.1517/14728214.2015.1049996] [Cited by in Crossref: 54] [Cited by in F6Publishing: 35] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Cimino C, Maurel OM, Musumeci T, Bonaccorso A, Drago F, Souto EMB, Pignatello R, Carbone C. Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems. Pharmaceutics 2021;13:327. [PMID: 33802570 DOI: 10.3390/pharmaceutics13030327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V. Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurol Int 2021;13:640-58. [PMID: 34940748 DOI: 10.3390/neurolint13040062] [Reference Citation Analysis]
3 Freret T, Largilliere S, Nee G, Coolzaet M, Corvaisier S, Boulouard M. Fast Anxiolytic-Like Effect Observed in the Rat Conditioned Defensive Burying Test, after a Single Oral Dose of Natural Protein Extract Products. Nutrients 2021;13:2445. [PMID: 34371954 DOI: 10.3390/nu13072445] [Reference Citation Analysis]
4 [DOI: 10.1101/811737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Landolt S, Rosemann T, Blozik E, Brüngger B, Huber CA. Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes. Neuropsychiatr Dis Treat 2021;17:1021-34. [PMID: 33880026 DOI: 10.2147/NDT.S290104] [Reference Citation Analysis]
6 Bourin M. Experimental Anxiety Model for Anxiety Disorders: Relevance to Drug Discovery. In: Kim Y, editor. Anxiety Disorders. Singapore: Springer; 2020. pp. 169-84. [DOI: 10.1007/978-981-32-9705-0_11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Panayotis N, Sheinin A, Dagan SY, Tsoory MM, Rother F, Vadhvani M, Meshcheriakova A, Koley S, Marvaldi L, Song DA, Reuveny E, Eickholt BJ, Hartmann E, Bader M, Michaelevski I, Fainzilber M. Importin α5 Regulates Anxiety through MeCP2 and Sphingosine Kinase 1. Cell Rep 2018;25:3169-3179.e7. [PMID: 30540948 DOI: 10.1016/j.celrep.2018.11.066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM, Wittchen H. Anxiety disorders. Nat Rev Dis Primers 2017;3. [DOI: 10.1038/nrdp.2017.24] [Cited by in Crossref: 154] [Cited by in F6Publishing: 134] [Article Influence: 30.8] [Reference Citation Analysis]
9 Lopes LT, Canto-de-Souza L, Baptista-de-Souza D, de Souza RR, Nunes-de-Souza RL, Canto-de-Souza A. The interplay between 5-HT2C and 5-HT3A receptors in the dorsal periaqueductal gray mediates anxiety-like behavior in mice. Behav Brain Res 2022;417:113588. [PMID: 34547341 DOI: 10.1016/j.bbr.2021.113588] [Reference Citation Analysis]
10 Hasler G, Buchmann A, Haynes M, Müller ST, Ghisleni C, Brechbühl S, Tuura R. Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy. Transl Psychiatry 2019;9:170. [PMID: 31213596 DOI: 10.1038/s41398-019-0500-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Rakib A, Ahmed S, Islam MA, Uddin MMN, Paul A, Chy MNU, Emran TB, Seidel V. Pharmacological studies on the antinociceptive, anxiolytic and antidepressant activity of Tinospora crispa. Phytother Res 2020;34:2978-84. [PMID: 32430999 DOI: 10.1002/ptr.6725] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
12 Panayotis N, Freund PA, Marvaldi L, Shalit T, Brandis A, Mehlman T, Tsoory MM, Fainzilber M. β-sitosterol reduces anxiety and synergizes with established anxiolytic drugs in mice. Cell Rep Med 2021;2:100281. [PMID: 34095883 DOI: 10.1016/j.xcrm.2021.100281] [Reference Citation Analysis]
13 Fakira AK, Lueptow LM, Trimbake NA, Devi LA. PEN Receptor GPR83 in Anxiety-Like Behaviors: Differential Regulation in Global vs Amygdalar Knockdown. Front Neurosci 2021;15:675769. [PMID: 34512237 DOI: 10.3389/fnins.2021.675769] [Reference Citation Analysis]
14 Azevedo H, Ferreira M, Costa RW, Russo V, Russo E, Mascarello A, Guimarães CRW. Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;95:109707. [DOI: 10.1016/j.pnpbp.2019.109707] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
15 Warren WG, Papagianni EP, Stevenson CW, Stubbendorff C. In it together? The case for endocannabinoid-noradrenergic interactions in fear extinction. Eur J Neurosci 2021. [PMID: 33759226 DOI: 10.1111/ejn.15200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Costache ME, Frick A, Månsson K, Engman J, Faria V, Hjorth O, Hoppe JM, Gingnell M, Frans Ö, Björkstrand J, Rosén J, Alaie I, Åhs F, Linnman C, Wahlstedt K, Tillfors M, Marteinsdottir I, Fredrikson M, Furmark T. Higher- and lower-order personality traits and cluster subtypes in social anxiety disorder. PLoS One 2020;15:e0232187. [PMID: 32348331 DOI: 10.1371/journal.pone.0232187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Ro Y, Noronha M, Mirza B, Ansari R, Gerlai R. The Tapping Assay: A Simple Method to Induce Fear Responses in Zebrafish. Behav Res Methods 2021. [PMID: 34918220 DOI: 10.3758/s13428-021-01753-9] [Reference Citation Analysis]
18 Green TA, Baracz SJ, Everett NA, Robinson KJ, Cornish JL. Differential effects of GABAA receptor activation in the prelimbic and orbitofrontal cortices on anxiety. Psychopharmacology (Berl) 2020;237:3237-47. [PMID: 32666257 DOI: 10.1007/s00213-020-05606-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol Ther 2019;204:107402. [PMID: 31470029 DOI: 10.1016/j.pharmthera.2019.107402] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 14.7] [Reference Citation Analysis]
20 Bu H, He A, Gong N, Huang L, Liang K, Kastelic K, Ma J, Liu Y, Chen ST, Chi X. Optimal movement behaviors: correlates and associations with anxiety symptoms among Chinese university students. BMC Public Health 2021;21:2052. [PMID: 34753485 DOI: 10.1186/s12889-021-12116-6] [Reference Citation Analysis]
21 Skelley JW, Deas CM, Curren Z, Ennis J. Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association 2020;60:253-61. [DOI: 10.1016/j.japh.2019.11.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
22 Scherf-Clavel M, Weber H, Deckert J, Erhardt-Lehmann A. The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics. Expert Opin Drug Metab Toxicol 2021;:1-12. [PMID: 34643143 DOI: 10.1080/17425255.2021.1991912] [Reference Citation Analysis]
23 Little A, Byrne C, Coetzer R. The effectiveness of cognitive behaviour therapy for reducing anxiety symptoms following traumatic brain injury: A meta-analysis and systematic review. NeuroRehabilitation 2021;48:67-82. [PMID: 33361617 DOI: 10.3233/NRE-201544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wu Y, Murray GK, Byrne EM, Sidorenko J, Visscher PM, Wray NR. GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nat Commun 2021;12:1146. [PMID: 33608531 DOI: 10.1038/s41467-021-21280-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
25 Cao Q, Wang J, Hao Y, Zhao F, Fu R, Yu Y, Wang J, Niu R, Bian S, Sun Z. Exercise Ameliorates Fluoride-induced Anxiety- and Depression-like Behavior in Mice: Role of GABA. Biol Trace Elem Res 2021. [PMID: 33825162 DOI: 10.1007/s12011-021-02678-2] [Reference Citation Analysis]
26 Macías-Carballo M, Rosas-Navarro S, López-Meraz ML, Beltran-Parrazal L, Morgado-Valle C. Anxiolytic effect of chronic intake of supplemental magnesium chloride in rat. Behav Brain Res 2021;413:113460. [PMID: 34252502 DOI: 10.1016/j.bbr.2021.113460] [Reference Citation Analysis]
27 Clark T, Hapiak V, Oakes M, Mills H, Komuniecki R. Monoamines differentially modulate neuropeptide release from distinct sites within a single neuron pair. PLoS One 2018;13:e0196954. [PMID: 29723289 DOI: 10.1371/journal.pone.0196954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
28 Moazzem Hossen SM, Akramul Hoque Tanim M, Shahadat Hossain M, Ahmed Sami S, Uddin Emon N. Deciphering the CNS anti-depressant, antioxidant and cytotoxic profiling of methanol and aqueous extracts of Trametes versicolor and molecular interactions of its phenolic compounds. Saudi J Biol Sci 2021;28:6375-83. [PMID: 34764755 DOI: 10.1016/j.sjbs.2021.07.016] [Reference Citation Analysis]
29 Zhou Y, Loeza-Cabrera M, Liu Z, Aleman-Meza B, Nguyen JK, Jung SK, Choi Y, Shou Q, Butcher RA, Zhong W. Potential Nematode Alarm Pheromone Induces Acute Avoidance in Caenorhabditis elegans. Genetics 2017;206:1469-78. [PMID: 28495959 DOI: 10.1534/genetics.116.197293] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
30 Silote GP, de Oliveira SFS, Ribeiro DE, Machado MS, Andreatini R, Joca SRL, Beijamini V. Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings. Prog Neuropsychopharmacol Biol Psychiatry 2020;100:109878. [PMID: 31982463 DOI: 10.1016/j.pnpbp.2020.109878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Nasir M, Trujillo D, Levine J, Dwyer JB, Rupp ZW, Bloch MH. Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology. Front Psychiatry 2020;11:548505. [PMID: 33329087 DOI: 10.3389/fpsyt.2020.548505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Mellifont D. Neuro magnifico! An exploratory study critically reviewing news text reporting of anxiety-related work performance strengths, challenges and support measures. Work 2019;63:435-46. [PMID: 31282452 DOI: 10.3233/WOR-192950] [Reference Citation Analysis]
33 Yang TY, Jang EY, Ryu Y, Lee GW, Lee EB, Chang S, Lee JH, Koo JS, Yang CH, Kim HY. Effect of acupuncture on Lipopolysaccharide-induced anxiety-like behavioral changes: involvement of serotonin system in dorsal Raphe nucleus. BMC Complement Altern Med 2017;17:528. [PMID: 29228944 DOI: 10.1186/s12906-017-2039-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
34 Chen X, van Gerven J, Cohen A, Jacobs G. Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety. Acta Pharmacol Sin 2019;40:571-82. [PMID: 30518829 DOI: 10.1038/s41401-018-0185-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
35 Andrejew R, Oliveira-Giacomelli Á, Ribeiro DE, Glaser T, Arnaud-Sampaio VF, Lameu C, Ulrich H. The P2X7 Receptor: Central Hub of Brain Diseases. Front Mol Neurosci 2020;13:124. [PMID: 32848594 DOI: 10.3389/fnmol.2020.00124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
36 Wright M, Di Ciano P, Brands B. Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence. Cannabis Cannabinoid Res 2020;5:191-6. [PMID: 32923656 DOI: 10.1089/can.2019.0052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Canzian J, Müller TE, Franscescon F, Michelotti P, Fontana BD, Costa FV, Rosemberg DB. Modeling psychiatric comorbid symptoms of epileptic seizures in zebrafish. J Psychiatr Res 2019;119:14-22. [PMID: 31542703 DOI: 10.1016/j.jpsychires.2019.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
38 Silva Dos Santos J, Gonçalves Cirino JP, de Oliveira Carvalho P, Ortega MM. The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review. Front Pharmacol 2020;11:565700. [PMID: 33519431 DOI: 10.3389/fphar.2020.565700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
39 Kafle OP, Wang X, Cheng S, Ding M, Li P, Cheng B, Liang X, Liu L, Du Y, Ma M, Zhang L, Zhao Y, Wen Y, Zhang F. Genetic Correlation Analysis and Transcriptome-wide Association Study Suggest the Overlapped Genetic Mechanism between Gout and Attention-deficit Hyperactivity Disorder. Can J Psychiatry 2021;66:1077-84. [PMID: 33155823 DOI: 10.1177/0706743720970844] [Reference Citation Analysis]
40 Papagianni EP, Stevenson CW. Cannabinoid Regulation of Fear and Anxiety: an Update. Curr Psychiatry Rep 2019;21:38. [PMID: 31030284 DOI: 10.1007/s11920-019-1026-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
41 Van Eeghem V, El Arfani A, Anthoula A, Walrave L, Pourkazemi A, Bentea E, Demuyser T, Smolders I, Stiens J. Selective changes in locomotor activity in mice due to low-intensity microwaves amplitude modulated in the EEG spectral domain. Neuroscience 2017;359:40-8. [PMID: 28687311 DOI: 10.1016/j.neuroscience.2017.06.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Wickramasekara RN, Bockman C, Hanke J, Schwegler H, McGee J, Walsh E, Yilmazer-Hanke D. Alpha2-adrenergic dysregulation in congenic DxH recombinant inbred mice selectively bred for a high fear-sensitized (H-FSS) startle response. Pharmacol Biochem Behav 2020;188:172835. [PMID: 31805289 DOI: 10.1016/j.pbb.2019.172835] [Reference Citation Analysis]
43 Chen C, Zhong Z, Xin Z, Zhang S, Yu C. A new stress model by predatory sound produces persistent anxiety-like behaviours in male SD rats but not ICR mice. Applied Animal Behaviour Science 2019;220:104843. [DOI: 10.1016/j.applanim.2019.104843] [Reference Citation Analysis]